About CVRx, Inc. Common Stock
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Market Cap
$0.33B
Employees
206
Listed Since
June 30, 2021
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.cvrx.comPhone
(763) 416-2850
Headquarters
9201 WEST BROADWAY AVENUE
MINNEAPOLIS, MN 55445
CIK
0001235912